Back to Search Start Over

A small-molecule degron with a phenylpropionic acid scaffold.

Authors :
Tomoshige S
Komatsu F
Kikuchi T
Sugiyama M
Kawasaki Y
Ohgane K
Furuyama Y
Sato S
Ishikawa M
Kuramochi K
Source :
Bioorganic & medicinal chemistry [Bioorg Med Chem] 2024 Jul 15; Vol. 109, pp. 117789. Date of Electronic Publication: 2024 Jun 05.
Publication Year :
2024

Abstract

Targeted protein degradation (TPD), employing proteolysis-targeting chimeras (PROTACs) composed of ligands for both a target protein and ubiquitin ligase (E3) to redirect the ubiquitin-proteasome system (UPS) to the target protein, has emerged as a promising strategy in drug discovery. However, despite the vast number of E3 ligases, the repertoire of E3 ligands utilized in PROTACs remains limited. Here, we report the discovery of a small-molecule degron with a phenylpropionic acid skeleton, derived from a known ligand of S-phase kinase-interacting protein 2 (Skp2), an E3 ligase. We used this degron to design PROTACs inducing proteasomal degradation of HaloTag-fused proteins, and identified key structural relationships. Surprisingly, our mechanistic studies excluded the involvement of Skp2, suggesting that this degron recruits other protein(s) within the UPS.<br />Competing Interests: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.<br /> (Copyright © 2024 The Authors. Published by Elsevier Ltd.. All rights reserved.)

Details

Language :
English
ISSN :
1464-3391
Volume :
109
Database :
MEDLINE
Journal :
Bioorganic & medicinal chemistry
Publication Type :
Academic Journal
Accession number :
38870716
Full Text :
https://doi.org/10.1016/j.bmc.2024.117789